Immune Globulin

Jim Lichauer, Meryl Biksacky, and Conor Hanrahan discuss the strategies Intermountain Healthcare implemented to improve their immune globulin utilization.

 

Guest speaker:
Meryl Biksacky, PharmD
Pharmacist, Drug Information Specialist
Drug Shortage Management CO-Lead
Intermountain Healthcare Drug Information Services

 

Conor Hanrahan, PharmD, MS, BCPS, CPHQ
Medication Policy, Outcomes and Stewardship Director
System PGY1 Pharmacy Residency Program Director
Intermountain Healthcare Pharmacy Services

 

Moderator:
Jim Lichauer, PharmD, BCPS, FASHP
Sr Performance Improvement Program Director, Pharmacy
Vizient

 

Show Notes:

[01:50] Intermountain Healthcare is a complex system.

[03:19] Challenges included the size and scale of the organization, drug shortages, as well as technology and data capture issues.

[05:30] The development of IG appropriate use guidelines was intricate and enterprise-wide.

[08:21] A medication use evaluation was conducted.  

[10:08] Evaluation of adherence to weight-based dosing strategies produced shocking results.  

[11:41] Surveying stakeholders revealed a lack of awareness of internal guidelines and standards. 

[12:42] A formal policy to optimize IG weight-based dosing is in the process of being approved.

[13:35] Advice for those planning similar strategies includes system-wide collaboration, establishing and monitoring adherence rates, standardization, and quantification of cost savings.

[15:12] Intermountain Healthcare has exciting developments on the horizon.

 

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Spotify

Google Podcasts

Android

Stitcher

RSS Feed